Arca Biopharma | ABIO - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Amgen USD 657M 4M 2026-03
Arca Biopharma USD 504K 246K 2024-09
Biogen USD 72.6M 12.6M 2025-06
Bristol-Myers Squibb USD 411M 21M 2026-03
Capricor Therapeutics 3.05M 2.46M 2025-12
Cipla INR 140.3M 8.5M 2025-12
Compugen USD 954K 116K 2025-09
CSL USD 215M 111M 2025-12
Cytokinetics USD 30.33M 4.01M 2025-12
Daiichi Sankyo JPY 2.16B 1.33B 2025-12
Gilead Sciences USD 255M 1000K 2025-12
GlaxoSmithKline GBP 167M 21M 2026-03
Grifols EUR 156.07M 31.46M 2025-09
Laboratory Of America USD 55.1M 100K 2026-03
Myriad Genetics USD 4.4M 600K 2025-12
Otsuka Holdings JPY 2.21B 866M 2025-12
Pfizer USD 711M 59M 2025-12
United Therapeutics USD 3.1M 100K 2025-12